Eloxx Pharmaceuticals, Inc. (ELOX) › Total AssetsEloxx Pharmaceuticals, Inc. (ELOX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $8.60M2012: $6.95M2013: $7.10M2014: $33.33M2015: $19.55M2016: $3.13M2017: $24.78M2018: $50.72M2019: $58.95M2020: $26.48M2021: $45.14M2022: $21.12M2023: $1.71M2024: $2.98M2025: $5.27M$5.27M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$5.27M+77.1%2024$2.98M+73.8%2023$1.71M-91.9%2022$21.12M-53.2%2021$45.14M+70.5%2020$26.48M-55.1%2019$58.95M+16.2%2018$50.72M+104.6%2017$24.78M+692.3%2016$3.13M-84.0%2015$19.55M-41.4%2014$33.33M+369.7%2013$7.10M+2.1%2012$6.95M-19.1%2011$8.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share